Jane Street’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-23,200
Closed -$83.1K 9050
2022
Q4
$83.1K Sell
23,200
-2,700
-10% -$11.5K ﹤0.01% 8194
2022
Q3
$104K Sell
25,900
-11,100
-30% -$57K ﹤0.01% 8633
2022
Q2
$165K Sell
37,000
-45,700
-55% -$330K ﹤0.01% 8332
2022
Q1
$702K Sell
82,700
-249,600
-75% -$1.75M ﹤0.01% 6843
2021
Q4
$2.93M Sell
332,300
-41,300
-11% -$393K ﹤0.01% 3735
2021
Q3
$3.88M Buy
373,600
+51,800
+16% +$452K ﹤0.01% 3164
2021
Q2
$3.38M Buy
321,800
+8,700
+3% +$85.9K ﹤0.01% 3360
2021
Q1
$3.22M Buy
+313,100
New +$4.36M ﹤0.01% 3114

Other funds holding SRTA

Jane Street's SRTA Position: Q1 2026 in Review

Jane Street reduced its Strata Critical Medical Inc (SRTA) stake by 12% in Q1 2026, selling an estimated $160K and leaving 236,231 shares worth $987K. The position accounts for ﹤0.01% of the portfolio, ranked #6519.

Jane Street first reported a position in SRTA in Q4 2020 and has held it in 19 quarters since. The position peaked at $1.3M in Q4 2025. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Jane Street held 236,231 shares of Strata Critical Medical Inc worth $987K as of Q1 2026.
  • Jane Street sold 33,218 Strata Critical Medical Inc shares in Q1 2026, an estimated $160K.
  • Strata Critical Medical Inc made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #6519 holding.
  • Jane Street first reported a position in Strata Critical Medical Inc in Q4 2020 and has held it in 19 quarters since.
  • Jane Street's Strata Critical Medical Inc position peaked at $1.3M in Q4 2025.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.